8-K - Actuate Therapeutics Inc | StockGist

Current Report Details

Event Type

Material Agreement

Other Event

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On September 10, 2025, Actuate Therapeutics, Inc. (the “Company”) entered into an Underwriting Agreement (the “Agree

Material Agreement

$7.00$15.0M

8.01

Other Events. The Company issued press releases announcing the launch and pricing of the Offering on September 9, 2025 and September 10, 2025, respectively. Cop

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits The following exhibits are filed with this report: Exhibit Number Exhibit Description 1.1 Underwriting Agreement

Exhibits Only

Source Document

Exhibits (5)

1.1

UNDERWRITING AGREEMENT

5.1

LEGAL OPINION

8-K

CURRENT REPORT

99.1

PRESS RELEASE

99.2

PRESS RELEASE